Glycan Therapeutics offers innovative solutions for design, synthesis, analysis, and validation of glycosaminoglycans (GAGs) specifically heparan sulfate and chondroitin sulfate. Glycan Therapeutics activities include producing and selling research reagents, analytical and microarray services, and a drug development program.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):